Rashmi Bharti
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 5
- Microbiology top 5%
- Cancer Research top 10%
- Molecular Medicine top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 4
- Cancer-related Molecular Pathways 3
- Cytokine Signaling Pathways and Interactions 3
-
- Cancer Research and Treatments 5
-
- Cell death mechanisms and regulation 3
-
- Nanoplatforms for cancer theranostics 3
-
- Microbial Natural Products and Biosynthesis 2
- Co-authors
- Mahitosh MandalGoutam DeyRamkrishna SenB. N. Prashanth KumarKaushik DeySantanu ChattopadhyaySudipta PanjaShashi Rajput
- Partner nations
- IndiaUnited StatesCzechia
In The Last Decade
Rashmi Bharti
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 111
- Biomaterials 182
- Microbiology 84
- Cancer Research 171
- Molecular Medicine 47
- Oncology 241
Countries citing papers authored by Rashmi Bharti
This map shows the geographic impact of Rashmi Bharti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rashmi Bharti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rashmi Bharti more than expected).
Fields of papers citing papers by Rashmi Bharti
This network shows the impact of papers produced by Rashmi Bharti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rashmi Bharti. The network helps show where Rashmi Bharti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rashmi Bharti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 27 | |
| 6 | 2019 | 31 | |
| 7 | 2019 | 24 | |
| 8 | 2018 | 37 | |
| 9 | 2017 | 33 | |
| 10 | 2017 | 41 | |
| 11 | 2016 | 196 | |
| 12 | 2016 | 27 | |
| 13 | 2016 | 28 | |
| 14 | 2016 | 66 | |
| 15 | 2015 | 97 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 63 | |
| 18 | 2014 | 45 | |
| 19 | 2014 | 29 | |
| 20 | PKI 166 induced redox signalling and apoptosis through activation of p53, MAP kinase and caspase pathway in epidermoid carcinoma. | 2012 | 7 |
About Rashmi Bharti
Rashmi Bharti is a scholar working on Biotechnology, Molecular Medicine and Biomaterials, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Cancer Research and Treatments (5 papers), Cancer Cells and Metastasis (4 papers), Cell death mechanisms and regulation (3 papers), Cancer-related Molecular Pathways (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Biomaterials (182 citations), Microbiology (84 citations) and Cancer Research (171 citations). Rashmi Bharti has collaborated with scholars based in India, United States and Czechia. Frequent co-authors include Mahitosh Mandal, Goutam Dey, Ramkrishna Sen, B. N. Prashanth Kumar, Kaushik Dey, Santanu Chattopadhyay, Sudipta Panja, Shashi Rajput, Anjan Kumar Das and Ipsita Pal. Their work appears in journals such as Chemistry of Materials, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.